Center for Scientific Review; Notice of Closed Meetings, 4898-4899 [2022-01882]
Download as PDF
<![CDATA[
4898
Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices
members of the Committee (when
additional voting members are added to
the Committee to provide needed
expertise, a quorum will be based on the
combined total of regular and added
members) or (2) to comprise a quorum
when, because of unforeseen
circumstances, a quorum is or will be
lacking. Because of the size of the
Committee and the variety in the types
of issues that it will consider, FDA may,
in connection with a particular
committee meeting, specify a quorum
that is less than a majority of the current
voting members. The Agency’s
regulations (21 CFR 14.22(d)) authorize
a committee charter to specify quorum
requirements.
If functioning as a medical device
panel, a non-voting representative of
consumer interests and a non-voting
representative of industry interests will
be included in addition to the voting
members.
Further information regarding the
most recent charter and other
information can be found at https://
www.fda.gov/advisory-committees/
vaccines-and-related-biologicalproducts-advisory-committee/chartervaccines-and-related-biologicalproducts-advisory-committee or by
contacting the Designated Federal
Officer (see FOR FURTHER INFORMATION
CONTACT). In light of the fact that no
change has been made to the committee
name or description of duties, no
amendment will be made to 21 CFR
14.100.
This document is issued under the
Federal Advisory Committee Act (5
U.S.C. app.). For general information
related to FDA advisory committees,
please visit us at https://www.fda.gov/
AdvisoryCommittees/default.htm.
Dated: January 24, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–01858 Filed 1–28–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
khammond on DSKJM1Z7X2PROD with NOTICES
Meeting of the Advisory Committee on
Childhood Vaccines
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
SUMMARY:
VerDate Sep<11>2014
17:38 Jan 28, 2022
Jkt 256001
Commission on Childhood Vaccines
(ACCV) will hold public meetings for
the 2022 calendar year (CY).
Information about the ACCV, agendas,
and materials for these meetings can be
found on the ACCV website at https://
www.hrsa.gov/advisory-committees/
vaccines/.
DATES: ACCV meetings will be held on:
• March 3, 2022, 10:00 a.m. Eastern
Time (ET)–4:00 p.m. ET;
• June 2, 2022, 10:00 a.m. ET–4:00
p.m. ET;
• September 1, 2022, 10:00 a.m. ET–
4:00 p.m. ET; and
• December 1, 2022, 10:00 a.m. ET–
4:00 p.m. ET.
ADDRESSES: Meetings may be held inperson or virtually. For updates on how
the meeting will be held, visit the ACCV
website 30 business days before the
meeting date, where instructions for
joining meetings either in-person or
remotely will be posted. In-person
ACCV meetings will be held at 5600
Fishers Lane, Rockville, Maryland
20857. For meeting information
updates, go to the ACCV website
meeting page at https://www.hrsa.gov/
advisory-committees/vaccines/
meetings.html.
FOR FURTHER INFORMATION CONTACT:
Annie Herzog, Division of Injury
Compensation Programs, HRSA, 5600
Fishers Lane, 08N186B, Rockville,
Maryland 20857; 301–443–6634; or
ACCV@HRSA.gov.
SUPPLEMENTARY INFORMATION: The ACCV
provides advice and recommendations
to the Secretary of HHS on policy,
program development, and other issues
related to the implementation of the
National Vaccine Injury Compensation
Program and concerning other matters
as described under section 2119 of the
Public Health Service Act (42 U.S.C.
300aa–19).
Since priorities dictate meeting times,
be advised that times and agenda items
are subject to change. Refer to the ACCV
website listed above for any meeting
updates that may occur. For CY 2022
meetings, agenda items may include,
but are not limited to: Updates from the
Division of Injury Compensation
Programs, Department of Justice, Office
of Infectious Disease and HIV/AIDS
Policy (HHS), Immunization Safety
Office (Centers for Disease Control and
Prevention), National Institute of
Allergy and Infectious Diseases
(National Institutes of Health) and
Center for Biologics, Evaluation and
Research (Food and Drug
Administration). Refer to the ACCV
website listed above for all current and
updated information concerning the CY
2022 ACCV meetings, including draft
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
agendas and meeting materials posted 5
calendar days before the meeting(s).
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the requested order and may
be limited as time allows. Requests to
submit a written statement or make oral
comments to ACCV should be sent to
Annie Herzog using the contact
information above at least 5 business
days before the meeting date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Annie
Herzog using the contact information
listed above at least 10 business days
before the meeting(s) they wish to
attend. If in-person meetings occur, they
will be held in a federal government
building and attendees must go through
a security check to enter the building.
Non-U.S. Citizen attendees must notify
HRSA of their planned attendance at
least 20 business days before the
meeting to facilitate their entry into the
building. All attendees are required to
present government-issued
identification before entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–01848 Filed 1–28–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Mechanisms of
Emotion, Stress and Health Study Section.
Date: February 24–25, 2022.
Time: 10:00 a.m. to 8:00 p.m.
E:\FR\FM\31JAN1.SGM
31JAN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 20 / Monday, January 31, 2022 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alyssa Todaro Brooks,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000F,
Bethesda, MD 20892, (301) 827–9299,
brooksaly@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; IRAP—
Infectious Diseases and Reproductive Health.
Date: March 2–3, 2022.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ananya Paria, MPH, MS,
CGH, DHSC, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1007H, Bethesda, MD 20892, (301)
827–6513, pariaa@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Genes, Genomes and Genetics.
Date: March 3–4, 2022.
Time: 7:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lystranne Alysia Maynard
Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–4809,
lystranne.maynard-smith@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Learning, Memory, Language,
Communication and Related Neuroscience.
Date: March 3–4, 2022.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jyothi Arikkath, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215,
Bethesda, MD 20892, (301) 435–1042,
arikkathj2@mail.nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Vaccines Against Microbial Diseases
Study Section.
Date: March 3–4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
VerDate Sep<11>2014
17:38 Jan 28, 2022
Jkt 256001
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neuropsychiatric and Neurologic Disorders.
Date: March 3–4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aurea D. De Sousa, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
Bethesda, MD 20892, (301) 827–6829,
aurea.desousa@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Behavioral Neuroscience.
Date: March 3–4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mei Qin, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–875–2215,
qinmei@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Fellowships:
Sensory and Motor Neurosciences, Cognition
and Perception.
Date: March 3–4, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph G. Rudolph, Ph.D.,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–408–
9098, josephru@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Maximizing
Investigators’ Research Award C Study
Section.
Date: March 3–4, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
4899
Dated: January 25, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–01882 Filed 1–28–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Study Section
Member Conflict Applications Review Panel.
Date: March 16, 2022.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700 B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: January 26, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–01902 Filed 1–28–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4898-4899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01882]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Biobehavioral Mechanisms of Emotion, Stress
and Health Study Section.
Date: February 24-25, 2022.
Time: 10:00 a.m. to 8:00 p.m.
[[Page 4899]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alyssa Todaro Brooks, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000F, Bethesda, MD 20892, (301)
827-9299, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; IRAP--Infectious Diseases and Reproductive Health.
Date: March 2-3, 2022.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ananya Paria, MPH, MS, CGH, DHSC, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007H, Bethesda, MD 20892, (301)
827-6513, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Genes, Genomes and Genetics.
Date: March 3-4, 2022.
Time: 7:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lystranne Alysia Maynard Smith, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-
402-4809, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Learning, Memory, Language, Communication and
Related Neuroscience.
Date: March 3-4, 2022.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jyothi Arikkath, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215, Bethesda, MD 20892, (301)
435-1042, [email protected].
Name of Committee: Applied Immunology and Disease Control
Integrated Review Group; Vaccines Against Microbial Diseases Study
Section.
Date: March 3-4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Wang, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4218, MSC 7812, Bethesda, MD 20892, (301) 435-
2778, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neuropsychiatric
and Neurologic Disorders.
Date: March 3-4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aurea D. De Sousa, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, Bethesda, MD 20892, (301)
827-6829, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Behavioral Neuroscience.
Date: March 3-4, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mei Qin, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-875-2215,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel Fellowships: Sensory and Motor Neurosciences, Cognition and
Perception.
Date: March 3-4, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph G. Rudolph, Ph.D., Chief and Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD
20892, 301-408-9098, [email protected].
Name of Committee: Cell Biology Integrated Review Group;
Maximizing Investigators' Research Award C Study Section.
Date: March 3-4, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD
20892, 301-435-2406, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 25, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01882 Filed 1-28-22; 8:45 am]
BILLING CODE 4140-01-P
